← Back to headlines
Arbutus Biopharma's Imdusiran Receives FDA Fast Track Designation
Arbutus Biopharma (ABUS) has been granted FDA Fast Track designation for its drug Imdusiran, accelerating its development and review process.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
'Astronauts back on Earth': Artemis II crew splashes down after record-breaking moon flyby – video
just now
Taal Volcano logs two minor eruptions, 48 seismic events in 24 hours
just now
Chernobyl Disaster's 40th Anniversary Marked Amid Ukraine War
11m ago
Researcher Highlights Untapped Potential of Human Waste as Fertilizer
16m ago